Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

Abstract Autologous stem cell transplantation (ASCT) is a well-established approach to treatment of patients with relapsed/refractory (R/R) Hodgkin lymphoma (HL) recommended by both the European Society for Medical Oncology and the National Comprehensive Cancer Network based on the results from rand...

Full description

Bibliographic Details
Main Authors: Anna Sureda, Marc André, Peter Borchmann, Maria G. da Silva, Christian Gisselbrecht, Theodoros P. Vassilakopoulos, Pier Luigi Zinzani, Jan Walewski
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Cancer
Subjects:
Consolidation
HL
Salvage
Stem cell transplantation
Online Access:http://link.springer.com/article/10.1186/s12885-020-07561-2

Internet

http://link.springer.com/article/10.1186/s12885-020-07561-2

Similar Items